# Cinryze

NDC: 42227-081
Generic name: HUMAN C1-ESTERASE INHIBITOR
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20081201

FDA application: BLA125267

## Active ingredients

- HUMAN C1-ESTERASE INHIBITOR: 500 [iU]/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42227-081"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42227-081